{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T13:31:14Z","timestamp":1788269474124,"version":"build-2803163510"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T00:00:00Z","timestamp":1650412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003030","name":"Ag\u00e8ncia de Gesti\u00f3 d'Ajuts Universitaris i de Recerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008799","name":"Gilead Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008799","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007512","name":"Universitat Rovira i Virgili","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007512","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009674","name":"Institut d'Investigaci\u00f3 Sanit\u00e0ria Pere Virgili","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009674","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Long-term elite controllers (LTECs) are a fascinating small subset of HIV individuals with viral and immunological HIV control in the long term that have been designated as models of an HIV functional cure. However, data on the LTEC phenotype are still scarce, and hence, the metabolomics and lipidomics signatures in the LTEC-extreme phenotype, LTECs with more than 10 years of viral and immunological HIV control, could be pivotal to finding the keys for functional HIV remission. Metabolomics and lipidomics analyses were performed using high-resolution mass spectrometry (ultra-high-performance liquid chromatography\u2013electrospray ionization\u2013quadrupole time of flight [UHPLC-(ESI) qTOF] in plasma samples of 13 patients defined as LTEC-extreme, a group of 20 LTECs that lost viral and\/or immunological control during the follow-up study (LTEC-losing) and 9 EC patients with short-term viral and immunological control (less than 5 years; no-LTEC patients). Long-term viral and immunological HIV-1 control was found to be strongly associated with elevated tricarboxylic acid (TCA) cycle function. Interestingly, of the nine metabolites identified in the TCA cycle, \u03b1-ketoglutaric acid (p = 0.004), a metabolite implicated in the activation of the mTOR complex, a modulator of HIV latency and regulator of several biological processes, was found to be a key metabolite in the persistent control. On the other hand, a lipidomics panel combining 45 lipid species showed an optimal percentage of separation and an ability to differentiate LTEC-extreme from LTEC-losing, revealing that an elevated lipidomics plasma profile could be a predictive factor for the reignition of viral replication in LTEC individuals.<\/jats:p>","DOI":"10.3389\/fimmu.2022.822272","type":"journal-article","created":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T05:56:52Z","timestamp":1650434212000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Elevated \u03b1-Ketoglutaric Acid Concentrations and a Lipid-Balanced Signature Are the Key Factors in Long-Term HIV Control"],"prefix":"10.3389","volume":"13","author":[{"given":"Jenifer","family":"Masip","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norma","family":"Rall\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Yeregui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Olona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvador","family":"Resino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M.","family":"Benito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Consuelo","family":"Vilad\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graciano","family":"Garc\u00eda-Pardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Alcam\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezequiel","family":"Ruiz-Mateos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"G\u00f3mez-Bertomeu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 A.","family":"Oteo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan A.","family":"Pineda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Mart\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f3nica","family":"Alba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesc","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquin","family":"Peraire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Rull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1080\/21505594.2020.1788887","article-title":"Elite Controllers: A Heterogeneous Group of HIV-Infected Patients","volume":"11","author":"Navarrete-Mu\u00f1oz","year":"2020","journal-title":"Virulence"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2007.08.010","article-title":"Human Immunodeficiency Virus Controllers: Mechanisms of Durable Virus Control in the Absence of Antiretroviral Therapy","volume":"27","author":"Deeks","year":"2007","journal-title":"Immunity"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0b013e328345a328","article-title":"Elite Controllers as a Model of Functional Cure","volume":"6","author":"Autran","year":"2011","journal-title":"Curr Opin HIV AIDS"},{"key":"B4","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ebiom.2019.03.004","article-title":"Immunometabolism is a Key Factor for the Persistent Spontaneous Elite Control of HIV-1 Infection","volume":"42","author":"Tarancon-Diez","year":"2019","journal-title":"EBioMedicine"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy599","article-title":"Proteomic Profile Associated With Loss of Spontaneous Human Immunodeficiency Virus Type 1 Elite Control","volume":"219","author":"Rodr\u00edguez-Gallego","year":"2019","journal-title":"J Infect Dis"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01805-17","article-title":"Factors Leading to the Loss of Natural Elite Control of HIV-1 Infection","volume":"92","author":"Pernas","year":"2018","journal-title":"J Virol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1086\/526786","article-title":"Genetic and Immunologic Heterogeneity Among Persons Who Control HIV Infection in the Absence of Therapy","volume":"197","author":"Pereyra","year":"2008","journal-title":"J Infect Dis"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32832b44c8","article-title":"Prevalence and Comparative Characteristics of Long-Term Nonprogressors and HIV Controller Patients in the French Hospital Database on HIV","volume":"23","author":"Grabar","year":"2009","journal-title":"AIDS"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.20411\/PAI.V5I1.364","article-title":"Antiretroviral Treatment for HIV Elite Controllers","volume":"5","author":"Ruiz-Mateos","year":"2020","journal-title":"Pathog Immun"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/CTM2.474","article-title":"Differential miRNA Plasma Profiles Associated With the Spontaneous Loss of HIV-1 Control: miR-199a-3p and its Potential Role as a Biomarker for Quick Screening of Elite Controllers","volume":"11","author":"Masip","year":"2021","journal-title":"Clin Transl Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1038\/S41598-020-58696-Y","article-title":"Permanent Control of HIV-1 Pathogenesis in Exceptional Elite Controllers: A Model of Spontaneous Cure","volume":"10","author":"Casado","year":"2020","journal-title":"Sci Rep"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001050","article-title":"Rate and Predictors of Progression in Elite and Viremic HIV-1 Controllers","volume":"30","author":"Leon","year":"2016","journal-title":"AIDS"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1021\/AC9019522","article-title":"FiehnLib: Mass Spectral and Retention Index Libraries for Metabolomics Based on Quadrupole and Time-of-Flight Gas Chromatography\/Mass Spectrometry","volume":"81","author":"Kind","year":"2009","journal-title":"Anal Chem"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkab382","article-title":"MetaboAnalyst 5.0: Narrowing the Gap Between Raw Spectra and Functional Insights","volume":"49","author":"Pang","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"B15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: Kyoto Encyclopedia of Genes and Genomes","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.2217\/FVL-2018-0207","article-title":"HIV Long-Term Non-Progressors Elite Controllers: An Interplay Between Host, Immune and Viral Factors","volume":"14","author":"L\u00f3pez-Gal\u00edndez","year":"2019","journal-title":"Future Virol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/NRI2922","article-title":"Immunometabolism: An Emerging Frontiers","volume":"11","author":"Mathis","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41577-020-0381-7","article-title":"Immunometabolism and HIV-1 Pathogenesis: Food for Thought","volume":"21","author":"S\u00e1ez-Ciri\u00f3n","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2011.04.007","article-title":"Metabolite Profiles of Human Immunodeficiency Virus Infected CD4+ T Cells and Macrophages Using LC-MS\/MS Analysis","volume":"415","author":"Hollenbaugh","year":"2011","journal-title":"Virology"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2009.02.008","article-title":"Autophagy, Antiviral Immunity, and Viral Countermeasures","volume":"1793","author":"Shoji-Kawata","year":"2009","journal-title":"Biochim Biophys Acta - Mol Cell Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/QAD.0000000000000128","article-title":"Increased Glucose Metabolic Activity Is Associated With CD4+ T-Cell Activation and Depletion During Chronic HIV Infection","volume":"28","author":"Palmer","year":"2014","journal-title":"AIDS"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/nri3198","article-title":"Regulation and Function of mTOR Signalling in T Cell Fate Decisions","volume":"12","author":"Chi","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1172\/JCI.INSIGHT.93230","article-title":"HIV-1 Selectively Targets Gut-Homing CCR6+CD4+ T Cells via mTOR-Dependent Mechanisms","volume":"2","author":"Planas","year":"2017","journal-title":"JCI Insight"},{"key":"B24","doi-asserted-by":"publisher","first-page":"103270","DOI":"10.1016\/J.EBIOM.2021.103270\/ATTACHMENT\/8BD22FE6-D066-4D98-B822-6C0665C0A542\/MMC4.PDF","article-title":"LILAC Pilot Study: Effects of Metformin on mTOR Activation and HIV Reservoir Persistence During Antiretroviral Therapy","volume":"65","author":"Planas","year":"2021","journal-title":"EBioMedicine"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2012.05.043","article-title":"Glutaminolysis Activates Rag-Mtorc1 Signaling","volume":"47","author":"Dur\u00e1n","year":"2012","journal-title":"Mol Cell"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000002007","article-title":"Metabolic Pathway Activation Distinguish Transcriptional Signatures of CD8 + T Cells From HIV-1 Elite Controllers HHS Public Access","volume":"32","author":"Chowdhury","year":"2018","journal-title":"AIDS"},{"key":"B27","doi-asserted-by":"publisher","first-page":"95","DOI":"10.7326\/L21-0297","article-title":"A Possible Sterilizing Cure of HIV-1 Infection Without Stem Cell Transplantation","volume":"175","author":"Turk","year":"2022","journal-title":"Ann Intern Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15548627.2021.1972403","article-title":"Autophagy-Dependent Glutaminolysis Drives Superior IL21 Production in HIV-1-Specific CD4 T Cells","author":"Loucif","year":"2021","journal-title":"Autophagy"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2021.1874134","article-title":"Lipophagy Confers a Key Metabolic Advantage That Ensures Protective CD8A T-Cell Responses Against HIV-1","volume":"17","author":"Loucif","year":"2021","journal-title":"Autophagy"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R200006200","article-title":"The Key Role of Anaplerosis and Cataplerosis for Citric Acid Cycle Function","volume":"277","author":"Owen","year":"2002","journal-title":"J Biol Chem"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2014.09.025","article-title":"Glutamine Oxidation Maintains the TCA Cycle and Cell Survival During Impaired Mitochondrial Pyruvate Transport","volume":"56","author":"Yang","year":"2014","journal-title":"Mol Cell"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/nri3793","article-title":"Cholesterol, Inflammation and Innate Immunity","volume":"15","author":"Tall","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2019.00785","article-title":"Altered Lipidome Composition Is Related to Markers of Monocyte and Immune Activation in Antiretroviral Therapy Treated Human Immunodeficiency Virus (HIV) Infection and in Uninfected Persons","author":"Bowman","year":"2019","journal-title":"Front Immunol"},{"key":"B34","article-title":"Dyslipidemia and its Treatment in HIV Infection","volume":"18","author":"Grunfeld","year":"2010","journal-title":"Top HIV Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2005.00273.x","article-title":"Effects of HIV Disease on Lipid, Glucose and Insulin Levels: Results From a Large Antiretroviral-Na\u00efve Cohort","volume":"6","author":"El-Sadr","year":"2005","journal-title":"HIV Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0171-2985(11)80543-7","article-title":"TNF-Induced Activation of NF-\u03bab","volume":"193","author":"Sch\u00fctze","year":"1995","journal-title":"Immunobiology"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/mBio.03444-20","article-title":"Phospholipid Metabolism Is Associated With Time to Hiv Rebound Upon Treatment Interruption","volume":"12","author":"Giron","year":"2021","journal-title":"MBio"},{"key":"B38","doi-asserted-by":"publisher","first-page":"22902","DOI":"10.1038\/SREP22902","article-title":"Proinflammatory Isoforms of IL-32 as Novel and Robust Biomarkers for Control Failure in HIV-Infected Slow Progressors","volume":"6","author":"El-Far","year":"2016","journal-title":"Sci Rep"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1093\/CID\/CIAA1129","article-title":"Anti-Cytomegalovirus Immunoglobulin G Is Linked to CD4 T-Cell Count Decay in Human Immunodeficiency Virus (HIV) Elite Controllers","volume":"73","author":"Isnard","year":"2021","journal-title":"Clin Infect Dis"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.822272\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T05:56:59Z","timestamp":1650434219000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.822272\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,20]]},"references-count":39,"alternative-id":["10.3389\/fimmu.2022.822272"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.822272","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,20]]},"article-number":"822272"}}